modipafant has been researched along with leukotriene e4 in 1 studies
| Studies (modipafant) | Trials (modipafant) | Recent Studies (post-2010) (modipafant) | Studies (leukotriene e4) | Trials (leukotriene e4) | Recent Studies (post-2010) (leukotriene e4) |
|---|---|---|---|---|---|
| 29 | 3 | 3 | 986 | 118 | 122 |
| Protein | Taxonomy | modipafant (IC50) | leukotriene e4 (IC50) |
|---|---|---|---|
| Canalicular multispecific organic anion transporter 1 | Rattus norvegicus (Norway rat) | 9.83 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, PJ; Carty, TJ; Chung, KF; Eskra, JD; O'Connor, BJ; Uden, S | 1 |
1 trial(s) available for modipafant and leukotriene e4
| Article | Year |
|---|---|
Inhibitory effect of UK,74505, a potent and specific oral platelet activating factor (PAF) receptor antagonist, on airway and systemic responses to inhaled PAF in humans.
Topics: Administration, Inhalation; Administration, Oral; Airway Resistance; Bronchoconstriction; Dihydropyridines; Dose-Response Relationship, Drug; Double-Blind Method; Eicosanoids; Humans; Imidazoles; Leukocyte Count; Leukotriene E4; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Thromboxane B2 | 1994 |